Skip to content

FRC Guided Therapy in Acute Respiratory Failure

Functional Residual Capacity Guided Alveolar Recruitment Strategy in Patients With Acute Respiratory Failure After Cardiac Surgery

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01280019
Enrollment
20
Registered
2011-01-20
Start date
2010-10-31
Completion date
2012-05-31
Last updated
2011-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure, Cardiac Surgery, Mechanical Ventilation

Keywords

functional residual capacity, electrical impedance tomography, inflammatory parameters

Brief summary

In ventilated patients with acute respiratory failure endotracheal suctioning may lead to alveolar derecruitment, which can be monitored by means of functional residual capacity (FRC) measurements. Regional distribution of ventilation can be followed at bedside using electrical impedance tomography. The investigators hypothesize that a FRC guided recruitment strategy, aimed at restoring a baseline FRC value after open endotracheal suctioning, improves oxygenation and regional distribution of ventilation. In addition the investigators research the impact of such a strategy on the inflammatory response to mechanical ventilation.

Interventions

Increase of airway pressures in a stepwise manner from set peak inspiratory pressure/ positive end-expiratory pressure up to 40/15 mbar and back over 2 minutes.

Sponsors

European Society of Intensive Care Medicine
CollaboratorOTHER
University of Luebeck
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* need for mechanical ventilation due to respiratory failure after cardiac surgery

Exclusion criteria

* circulatory failure, eg. need for high doses of inotropes or extracorporal cardiac support

Design outcomes

Primary

MeasureTime frameDescription
Regional ventilation6 hoursRegional distribution of ventilation over 6 hours of treatment

Secondary

MeasureTime frameDescription
arterial oxygenation and inflammation6 hoursChanges of arterial oxygenation and inflammatory parameters in the blood during 6 hours of treatment

Countries

Germany

Contacts

Primary ContactHermann Heinze, MD
Hermann.heinze@uk-sh.de

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026